OXT and obesity due to melanocortin 4 receptor deficiency: Intranasal oxytocin administration (24 IU, four times a day, over 8 weeks) didn’t prove effective for losing weight or enhancing body composition in obese adults, even though it slightly lowered how many calories they consumed in the short term, implying it might not be very useful for treating obesity (25).